Item 1A. RISK FACTORS

There have been no material changes in the Company’s risk factors from those disclosed in Viatris’ 2025 Form 10-K.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

There were no repurchases of the Company’s common stock during the three months ended March 31, 2026. Refer to Note 8 Earnings (Loss) per Share included in Part I, Item 1 of this Form 10-Q of this Form 10-Q for additional information regarding the Company’s authorized share repurchase program.